Medetomidine structure
|
Common Name | Medetomidine | ||
|---|---|---|---|---|
| CAS Number | 86347-14-0 | Molecular Weight | 200.279 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 381.9±11.0 °C at 760 mmHg | |
| Molecular Formula | C13H16N2 | Melting Point | 151.5 - 152.5ºC | |
| MSDS | N/A | Flash Point | 191.3±5.7 °C | |
Use of MedetomidineMedetomidine(Domtor) is a potent, highly selective α2-adrenoceptor agonist (Ki values are 1.08 and 1750 nM for α2- and α1-adrenoceptors respectively). IC50 value:Target: α2-adrenoceptorMedetomidine displays greater selectivity over α1-adrenoceptors than clonidine and UK 14,304 (1620-, 220- and 300-fold respectively). Medetomidine inhibits twitch response in electrically stimulated mouse vas deferens (pD2 = 9.0). Active in vivo; displays hypotensive, bradycardic, sedative, anxiolytic, hypothermic and analgesic effects. |
| Name | medetomidine |
|---|---|
| Synonym | More Synonyms |
| Description | Medetomidine(Domtor) is a potent, highly selective α2-adrenoceptor agonist (Ki values are 1.08 and 1750 nM for α2- and α1-adrenoceptors respectively). IC50 value:Target: α2-adrenoceptorMedetomidine displays greater selectivity over α1-adrenoceptors than clonidine and UK 14,304 (1620-, 220- and 300-fold respectively). Medetomidine inhibits twitch response in electrically stimulated mouse vas deferens (pD2 = 9.0). Active in vivo; displays hypotensive, bradycardic, sedative, anxiolytic, hypothermic and analgesic effects. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 381.9±11.0 °C at 760 mmHg |
| Melting Point | 151.5 - 152.5ºC |
| Molecular Formula | C13H16N2 |
| Molecular Weight | 200.279 |
| Flash Point | 191.3±5.7 °C |
| Exact Mass | 200.131348 |
| PSA | 28.68000 |
| LogP | 3.10 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.570 |
| Storage condition | -20°C |
| HS Code | 2933290090 |
|---|
| Precursor 8 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Medetomidine |
| 1H-Imidazole, 4-[1-(2,3-dimethylphenyl)ethyl]- |
| Medetomidina |
| 4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole |
| Medetomidine [inn:ban] |
| (rac)-4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole |
| Medetomidinum |
| 4-(1-(2,3-Dimethylphenyl)ethyl)-1H-imidazole |
| Medetomidina [spanish] |
| DoMtor |